Adage Capital Partners GP L.L.C. bought a new position in Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund bought 850,000 shares of the company’s stock, valued at approximately $2,448,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vivo Capital LLC […]

Related Keywords

Stifel Nicolaus , Piper Sandler , Vivo Capital , Capital Group International Inc , Nasdaq , Venture Partners Investment Advisor , Wells Fargo Company , Sphera Funds Management , Cantor Fitzgerald , Gracell Biotechnologies Inc , Adage Capital Partners , Gracell Biotechnologies , Free Report , Funds Management , Group International , Biotechnologies Inc , Visit Holdingschannel , Gracell Biotechnologies Daily ,